review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.2174/0929867323999160625124424 |
P698 | PubMed publication ID | 27356544 |
P50 | author | Silvia Pérez-Silanes | Q39676472 |
P2093 | author name string | Elsa Moreno-Viguri | |
Rocio Paucar | |||
P433 | issue | 28 | |
P921 | main subject | Chagas disease | Q649558 |
drug discovery | Q1418791 | ||
P304 | page(s) | 3154-3170 | |
P577 | publication date | 2016-06-26 | |
P1433 | published in | Current Medicinal Chemistry | Q3007710 |
P1476 | title | Challenges in Chagas Disease Drug Discovery: A Review | |
P478 | volume | 23 |
Q92774155 | Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity |
Q94464441 | High Throughput Approaches to Unravel the Mechanism of Action of a New Vanadium-Based Compound against Trypanosoma cruzi |
Q39188089 | Pediatric enteric neuropathies: diagnosis and current management |
Q57804131 | Trypanosoma cruzi Neurotrophic Factor Facilitates Cardiac Repair in a Mouse Model of Chronic Chagas Disease |
Search more.